HOME - Companies - News
 
 
18 November 2024

Trinity Capital Provides $40 Million in Growth Capital to Impress


Trinity Capital Inc. (NASDAQ: TRIN) (“Trinity”), a leading provider of diversified financial solutions to growth-oriented companies, today announced a commitment of $40 million in growth capital to Impress, a leading orthodontic chain in Europe specializing in invisible aligners.

Headquartered in Barcelona, Spain, Impress’s network of clinics spans multiple European countries and serves over 250,000 patients annually. The company’s recent acquisition of DrSmile has further solidified its leadership in key European markets.

“We’re excited to support Impress in their mission to make high-quality orthodontic care more accessible across Europe,” said Craig Fox, managing director of tech lending at Trinity. “Impress’s focus on clinical excellence, coupled with their innovative technology and scalable business model, positions them to make a meaningful impact in advancing healthcare standards.”

The $40 million debt financing from Trinity is part of a larger $117 million funding round for Impress. This capital will enable Impress to continue expanding, including plans to open 20 new clinics across Europe.

“We are thrilled to partner with Trinity Capital in this new funding round,” said Vladimir Lupenko, CEO of Impress. “With Trinity’s partnership, we look forward to expanding our clinic network and reaching more patients, ensuring that everyone has access to effective and affordable orthodontic solutions.”

Fieldfisher, a European law firm with practices in technology, financial services, energy and natural resources, and life sciences, represented Trinity in the transaction.

About Trinity Capital Inc.

Trinity Capital Inc. (NASDAQ: TRIN), an internally managed business development company, is a leading provider of diversified financial solutions to growth-stage companies with institutional equity investors. Trinity Capital’s investment objective is to generate current income and, to a lesser extent, capital appreciation through investments, including term loans, equipment financings, and equity-related investments. Trinity Capital believes it is one of a select group of specialty lenders with the depth of knowledge, experience, and track record in lending to growth-stage companies.

About Impress

Impress is Europe’s leading orthodontic chain, transforming smiles across Spain, Italy, Portugal, France, the UK, Germany, Sweden, the Netherlands, Ukraine, and the U.S. With a focus on medically driven orthodontic solutions, advanced R&D, and a high standard of clinical oversight, Impress specializes in patient-centered care powered by technological innovation. The company’s extensive network serves over 250,000 patients annually, making it Europe’s largest chain of invisible aligners.


Source: www.trinitycap.com

Related articles

Pre-injection anesthetic spray designed to transform dental injections from a workflow bottleneck into a fast efficient process.


Pre-injection anesthetic spray designed to transform dental injections from a workflow bottleneck into a fast efficient process.


The Cx Precoat Box is described as a first-of-its-kind streamlined orthodontic bracket storage system designed to optimize doctors’ efficiency, patient flow and wait time.


The children who attended the “Give Kids a Smile” clinic Saturday at the University of Michigan School of Dentistry received more than just free and immediate dental care.


Dr. Kenneth (DDS’75, Endo’78) and Beverly Spolnik have donated a large gift that will enable the renovation and construction of a dental school commons, a gathering space in the former Clinics A,...


Read more

Continuous innovation across the DEXIS ecosystem helps clinicians work with greater clarity, confidence, and efficiency


CrownPoint Partners announced the successful closing of a $9.2 million, five-property dental sale-leaseback portfolio located throughout Michigan.


Beginning November 1, Dentsply Sirona will expand its long-standing relationship with Midwest Dental Equipment & Supply beyond consumables to include its complete technology portfo


As the University of Colorado Anschutz School of Dental Medicine celebrates the graduating DDS Class of 2025, we are proud to recognize the students and faculty members whose excep


This peer-reviewed implantology article summarizes clinical evidence from Clinical oral implants research (2026). It focuses on findings that may help dental professionals evaluate treatment...


 
 
 
 

 
 
 
 

Most popular

 
 

Events